Sangamo BioSciences Announces Presentation of Phase 1b ZFP Therapeutic Data at American Diabetes Association Meeting
... 66 subjects) will be treated by
intramuscular injection of
60 mg of SB-509 (30 mg of SB-509 per ... group
(approximately 30 subjects) was treated by
intramuscular injection of 60 mg
of SB-509 (30 mg of SB-509 per ... 30 subjects) will be treated by
intramuscular injection of
60 mg of SB-509 (30 mg of SB-509 per ...
BioCryst Provides Peramivir Update and Reports First Quarter 2009 Financial Results
... to peramivir and all ten isolates were susceptible to peramivir.
intramuscular Peramivir Phase 2 Study Results for Seasonal Influenza
BioCryst also announced preliminary results from its Phase 2 study of
intramuscular (i.m.) peramivir for the treatment of seasonal influenza. While the study ...
Data from Phase 2 Study of Peramivir in Patients Hospitalized with Influenza Presented at the XI International Symposium on Respiratory Viral Infections
... studied in hospitalized and outpatient influenza, utilizing either an
intramuscular or intravenous formulation. A Phase 2 trial in outpatient influenza is ... Phase 2 clinical trials of peramivir did not receive adequate dosing by
intramuscular injection may not be correct, that HHS and the Food & Drug ...
Reproductive Partners Participates in New IVF Progesterone Delivery System Study
... national study to explore new IVF progesterone delivery systems replacing
intramuscular injections.
LOS ANGELES, Jan. 12 /PRNewswire/ -- Reproductive ... multi-center study exploring new progesterone delivery systems to replace
intramuscular injections. Patients going through in vitro fertilization (IVF) often ...
BioCryst Announces Initiation of Phase II Study of Intramuscular Peramivir for the Treatment of Seasonal Influenza
... (Nasdaq: BCRX ) today announced the initiation of a
Phase II study of
intramuscular (i.m.) peramivir for the treatment of
seasonal influenza.
The ... Phase II clinical trials of peramivir did not receive adequate dosing
by
intramuscular injection may not be correct, that HHS and the Food & Drug
Administration ...
ROXRO PHARMA Announces Positive Clinical Proof of Concept Results for Novel Intranasal Migraine Treatment
... has been widely used in the hospital setting
either intravenously or as an
intramuscular injection to treat
moderate-to-severe acute pain. ROXRO's clinical data show ROX-828 achieves
peak blood levels at least as fast as an
intramuscular injection of
ketorolac without the inconvenience and discomfort of a ...
MedImmune's Motavizumab Reduced RSV Hospitalizations by 83 Percent Among High-Risk Native American, Full-Term Infants in Placebo-Controlled Phase 3 study
... The randomized (2:1), double-blind study was designed to compare
monthly
intramuscular injections of motavizumab against placebo. After an
interim analysis ... Synagis, which was a significant product improvement
as a monthly
intramuscular injection for the prevention of severe RSV, as
well as being the first MAb ...
Video: FDA Approves INVEGA(R) SUSTENNA(TM) for the Acute and Maintenance Treatment of Schizophrenia
... Technology. Using this technology increases the rate of dissolution and enables the formulation of an aqueous suspension for once-monthly
intramuscular administration. INVEGA(R) SUSTENNA(TM) is manufactured by Janssen, Division of Ortho-McNeil-Janssen Pharmaceuticals, Inc, in the U.S.
About ...
PharmAthene Submits SparVax(TM) Regulatory Strategy to FDA
...
About SparVax(TM)
SparVax(TM) is a novel second generation recombinant protective (rPA) anthrax vaccine being developed for administration by
intramuscular injection. Phase I and Phase II clinical trials involving more than 700 healthy human subjects have been completed and showed that SparVax(TM) ...
RISPERDAL(R) CONSTA(R) (Risperidone) Long-Acting Treatment Delayed the Time to Relapse in Patients with Bipolar I Disorder
... is encapsulated in microspheres made of a biodegradable polymer, which are suspended in a water-based solution and administered to patients by
intramuscular injection once every two weeks. RISPERDAL(R) CONSTA(R) is manufactured by Alkermes, Inc. and marketed by Janssen, Division of Ortho-McNeil-Janssen ...
Nobilon Advances First Vaccine Into Human Trials - Intranasal Influenza Vaccine Begins Phase I Clinical Development
... but is up to 80% effective in preventing death. Nevertheless, current inactivated influenza vaccines have limitations and are underutilized.
intramuscular vaccination with needles is an important barrier for the acceptance of annual influenza vaccination, which may be overcome by intranasal application. ...
FDA Accepts Complete Response Submission to New Drug Application for NEBIDO(R)
... Administration (FDA) has accepted for review the complete response submission to the new drug application for NEBIDO(R) (testosterone undecanoate)
intramuscular injection, an investigational testosterone preparation for the treatment of male hypogonadism. FDA is targeting September 2, 2009 as the action date ...
Fertility Physicians of Northern California Researchers Test New Forms of Progesterone Medication for Luteal Support During IVF
... Calif., Jan. 5 /PRNewswire/ -- Women undergoing in vitro
fertilization (IVF) require progesterone medication to help support early
pregnancy, but the
intramuscular injections for some forms of this medication
can be painful for patients. Formulations of progesterone medication which
can be administered by ...
Landmark COPD Trial UPLIFT(R) Shows SPIRIVA(R) HandiHaler(R) Sustained Lung Function Improvements Over Four Years
... change in the color of phlegm,
wheezing, breathlessness with a duration of 3 or more days requiring
treatment with antibiotics and/or systemic (oral,
intramuscular or
intravenous) steroids.
SPIRIVA provided statistically significant improvements at all time
points in health-related quality of life, as measured ...
PharmAthene Presents Data for Protexia(R) and Valortim(R) at 2008 BARDA Industry Conference / PHEMCE Stakeholders Workshop
... Phase I clinical study, 46 human volunteers were administered
either a single dose of intravenous (IV) Valortim(R) (dose range 0.3
mg/kg-20 mg/kg) or
intramuscular Valortim(R) (100mg). Valortim(R) was found
to be safe and well-tolerated with no drug-related Grade 2-4 or serious
adverse events reported. PK ...
Alexza's AZ-004 (Staccato(R) Loxapine) Phase 3 Trial Meets Primary Endpoint of Treating Acute Agitation in Schizophrenic Patients
... or psychiatric units
in standard hospitals. Market research among psychiatrists indicates that
these physicians currently treat acute agitation with
intramuscular (IM)
injections, rapid-dissolve tablets or standard tablets. IM injections are
invasive, can be disconcerting to patients as they often require the ...
BioCryst Reports Positive Preliminary Results of a Shionogi & Co., Ltd. Sponsored Phase II Study of I.V. Peramivir for the Treatment of Influenza in the Outpatient Setting
... contained herein include that our belief that many subjects in
the Phase II clinical trials of peramivir did not receive adequate dosing
by
intramuscular injection may not be correct, that HHS and the Food & Drug
Administration (FDA) may not agree with our analysis, that HHS may further
condition, ...
Alexza Initiates Second Phase 3 Clinical Trial for AZ-004 (Staccato(R) Loxapine)
... or psychiatric units
in standard hospitals. Market research among psychiatrists indicates that
these physicians currently treat acute agitation with
intramuscular (IM)
injections, rapid-dissolve tablets or standard tablets. IM injections are
invasive, can be disconcerting to patients as they often require the ...
Vical Announces Breakthrough for Pandemic Influenza DNA Vaccines With Preliminary Human Data
... approximately 100 healthy volunteers age 18 to 45 at three
U.S. clinical sites. The trial was designed to assess safety and
immunogenicity following
intramuscular vaccination with needle and syringe
or with the Biojector(R) 2000 needle-free injection system in different
cohorts, and to evaluate monovalent and ...
Alexza Completes Enrollment in Phase 3 Clinical Trial with AZ-004 (Staccato(R) Loxapine) for Acute Agitation
... in psychiatric hospitals or psychiatric units in
standard hospitals.
Market research indicates that physicians currently treat acute
agitation with
intramuscular (IM) injections, rapid-dissolve tablets or
standard tablets. IM injections are invasive, can be disconcerting to
patients as they often require the ...
Sangamo BioSciences Provides Update on Diabetic Neuropathy Clinical Programs
... have completed enrollment. Subjects
were randomized to one of two groups in a 2:1 ratio. The larger group
(approximately 30 subjects) was treated by
intramuscular injection of 60 mg
of SB-509 (30 mg of SB-509 per leg) into the lower limb and will be treated
every 3 months. The remaining group (approximately 15 ...
U.S. Food and Drug Administration Approves ABILIFY(R) (aripiprazole) for the Acute Treatment of Manic and Mixed Episodes Associated With Bipolar I Disorder in Pediatric Patients (10 to 17 Years of Age)
... mg and 15
mg strengths. In addition, ABILIFY is available in a 1 mg/mL
nonrefrigerated Oral Solution and as a single-dose, ready-to-use solution
for
intramuscular injection 7.5 mg/mL. In adult patients, the recommended
ABILIFY(R) (aripiprazole) Oral target dose is 15 mg/day to 30 mg/day in
Bipolar I Disorder. ...
Clinical Update - Decapeptyl(R)/Trelstar(R) 6-Month Formulation in Advanced Prostate Cancer
... 4 or 12 weeks respectively. The 6-month formulation
will improve patient compliance and increase convenience and comfort with
the need of only one
intramuscular injection every 24 weeks," said Kamel
Besseghir, CEO of Debiopharm S.A.
About Decapeptyl(R)/Trelstar(R)
Triptorelin was licensed-in from Tulane ...
BioCryst Updates Peramivir Clinical Development Plan
... an update on activities
conducted following release of the preliminary Phase II data and outlined
the resulting clinical development plan for
intramuscular (i.m.) peramivir.
(Logo: http://www.newscom.com/cgi-bin/prnh/20030414/BIOCRYSTLOGO )
Following release of preliminary Phase II results in ...
Indevus Reports Additional Positive Phase III Trial Data for NEBIDO(R)
... most recent Phase III pharmacokinetic trial was an open-label
(unblinded) study that evaluated treatment with an initial 750 mg of NEBIDO
given via
intramuscular injection, followed 4-weeks later by an additional
750 mg loading injection and then 750 mg every 10 weeks thereafter.
Patients eligible for ...
Sangamo BioSciences Announces Completion of Enrollment of Phase 2 Clinical Trial of ZFP Therapeutic for Diabetic Neuropathy
... of 102 subjects have been enrolled into the trial. Subjects
were randomized to one of two groups in a 2:1 ratio. The larger group is
being treated by
intramuscular injection of 60 mg of SB-509 (30 mg of
SB-509 per leg) into the lower limb every 2 months. The remaining group is
receiving an equal volume of ...
MedImmune Presents New Pharmaco-Economic Data at American Academy of Pediatrics Regarding Infants at High Risk for RSV
... administered via four-hour intravenous infusion. In 1998,
MedImmune introduced Synagis, which was a significant product improvement
as a monthly
intramuscular injection for the prevention of severe RSV, as
well as being the first MAb to receive U.S. Food and Drug Administration
(FDA) approval for an ...
Lilly Files for European Approval of ALIMTA(R) (pemetrexed for injection) for First-Line Treatment of Non-Small Cell Lung Cancer
... of pemetrexed is 500
mg/m(squared) BSA, given by ten-minute infusion, on day 1 of each 21-day
cycle. Pre-medication: Supplement with 1000 micrograms
intramuscular vitamin
B12 and oral folic acid (350 to 1000 micrograms) to reduce toxicity (for
full details see Summary of Product Characteristics [SPC]). To ...
Vical Licensee Sanofi-aventis Initiates Phase 3 Trial to Reduce Amputations
... placebo-controlled Phase 3 trial
in approximately 500 patients with critical limb ischemia. Four doses of 4
mg each will be administered by
intramuscular injection at two-week
intervals, and follow-up will continue for one year. The primary endpoint
is the prevention of major amputation or of death. ...
Ozarelix Phase 2 Data Presented at 29th Congress of the Societe Internationale d'Urologie
... Alliance with AEterna Zentaris Ozarelix is a fourth generation Luteinizing Hormone Releasing Hormone
(LHRH) antagonist administered as an
intramuscular injection. In August
2004, Spectrum received an exclusive license from AEterna Zentaris to
develop and market ozarelix for all potential indications ...
Indevus Announces Submission of New Drug Application
... study that included the evaluation of the pharmacokinetics of
NEBIDO dosed as either 1000 mg every 12 weeks or as 750 mg every 12 weeks,
both via
intramuscular injection. The primary endpoints included a
responder analysis (based on guidelines provided from the FDA for average
testosterone concentrations ...
Georgia Reproductive Specialists Participates in Largest-Ever In Vitro Fertilization Clinical Trial in the World
... that are designed with the patient in
mind. Patients have been dissatisfied with current progesterone
supplements, such as progesterone-in-oil
intramuscular injections, which
can be painful, and suppositories and gels, which can be messy. With
ENDOMETRIN, they now have an effective, patient- friendly ...
Alexza's AZ-004 Phase IIa Trial Meets Primary Endpoint in Treating
Schizophrenic Patients With Acute Agitation
... acute agitation are typically
administered by
intramuscular injection, usually in a clinic or in
an emergency ... Treated patients are generally given
an
intramuscular injection of an atypical antipsychotic drug or a
sedative medication. However,
intramuscular injections are
invasive, can take 30 to 60 ...
New England Journal of Medicine Publishes New Data on Gardasil,
Merck's Cervical Cancer Vaccine
...
GARDASIL is a ready-to-use, three-dose,
intramuscular vaccine.
GARDASIL should be administered in three ... Interactions).
As with other
intramuscular injections, GARDASIL should not be
given to ... to the projected human dose on
a mg/kg basis) by
intramuscular injection. No adverse effects on
mating, ...
Data Published in The Lancet Show Gardasil was 100 Percent
Effective in Preventing High-Grade Vulvar and Vaginal Lesions
Caused by HPV Types 16 and 18
...
GARDASIL is a ready-to-use, three-dose,
intramuscular vaccine.
GARDASIL should be administered in three ... Interactions).
As with other
intramuscular injections, GARDASIL should not be
given to ... to the projected human dose on
a mg/kg basis) by
intramuscular injection. No adverse effects on
mating, ...
BioCryst Presents Phase I Peramivir Data at the Options for the
Control of Influenza Conference
... Pharmacokinetic and Safety Profile of the
intramuscular Formulation
of Peramivir Supports Further ... results from two Phase I
clinical studies of an
intramuscular (i.m.) formulation of
peramivir at the Options ... safety profile of peramivir
when given as an
intramuscular injection, and, secondly, the
concentrations of ...
New Study Confirms Role for Pertussis Immunization of Entire Family
in Reducing Infant Pertussis
... June 10, 2005. Adacel vaccine is administered as a single,
0.5mL dose by
intramuscular injection. It is similar to DAPTACEL(R)
(Diphtheria and Tetanus Toxoids ... components found in Adacel
vaccine should be carried out. Because any
intramuscular injection
can cause injection site hematoma, Adacel vaccine should not ...
Anthrax Monoclonal Antibody Valortim Demonstrates Therapeutic
Effect in New Primate Model of Established Anthrax Infection
... of PharmAthene. "As our Phase
I results have demonstrated, a single
intramuscular dose of
Valortim produces levels of antibodies in humans that correspond ... of Valortim in this model
using the potentially most clinically-useful
intramuscular route of
administration. In this study, the animals were challenged with ...
Anthrax Monoclonal Antibody Valortim(tm) Demonstrates Therapeutic
Effect in New Primate Model of Established Anthrax Infection
... of PharmAthene. "As our Phase
I results have demonstrated, a single
intramuscular dose of
Valortim produces levels of antibodies in humans that correspond ... of Valortim in this model
using the potentially most clinically-useful
intramuscular route of
administration. In this study, the animals were challenged with ...